Biotechnology News and Research

RSS

MedNet Solutions bolsters its iMedNet Partner Program

MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, has recently bolstered its iMedNet™ Partner Program, further distinguishing iMedNet as the eClinical solution of choice for Clinical Research Organizations (CROs) and healthcare consultants.

13 Feb 2015

BioMed Realty breaks ground on new 316,000 square foot campus in San Diego

Joined by San Diego political leaders and representatives of the life science community, BioMed Realty Trust, Inc. today broke ground on a new 316,000 square foot laboratory and office campus designed to meet the unique real estate needs of San Diego's thriving life science industry.

13 Feb 2015

Biotech experts to establish ethical guidelines in cellular biotechnology at BEINGS 2015

In May 2015 Atlanta will host Biotechnology and the Ethical Imagination: A Global Summit (BEINGS), an international summit drawing together the world's thought leaders on the highly debated issues of cellular biotechnology.

13 Feb 2015

New study indicates that malaria-causing parasite is unlikely to cross from animals to humans

In recent years, public health experts have increasingly explored the idea of eliminating the most dangerous malaria-causing parasite. But they have questioned whether getting rid of this species, called Plasmodium falciparum, would allow other species of the parasite to simply jump into the gap and start infecting humans with malaria.

13 Feb 2015

AMRI reports financial and operating results for Q4 and FY 2014

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2014.

12 Feb 2015

Epicore BioNetworks named one of 50 strongest companies on TSXV

Epicore BioNetworks Inc. is proud to announce that the Company has been selected by TSX Venture 50 as one of the 50 strongest companies on the TSXV.

12 Feb 2015

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

Amgen announced today that the Cellular, Tissue and Gene Therapies Advisory Committee and the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will jointly review the Company's Biologics License Application (BLA) for talimogene laherparepvec.

11 Feb 2015

ADDF, Pfizer's CTI collaborate to advance development of new drugs for Alzheimer's disease

The Alzheimer's Drug Discovery Foundation and Pfizer's Centers for Therapeutic Innovation announced today a collaboration designed to advance the development of new small-molecule drugs for Alzheimer's disease and related dementias. As part of the first-of-its kind collaboration in Alzheimer's, the ADDF and CTI will jointly invest in translational research projects, with a focus on novel Alzheimer's drug targets.

11 Feb 2015

Oncolytics' REOLYSIN receives FDA Orphan Drug Designation for treatment of ovarian cancer

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.

11 Feb 2015

Researchers close to novel therapy to treat levodopa-induced dyskinesia

Involuntary dyskinetic movements induced by treatment with levodopa (L-dopa) are a common problem for people with Parkinson's disease. Now, however, researchers at Karolinska Institutet and Lund University in Sweden seem to be close to a novel therapy to this distressing side effect.

11 Feb 2015

Dotmatics releases new version of Inventory module

Dotmatics, the leading provider of scientific informatics solutions and services, announced today the release of a new version of its Inventory module which is fully integrated with the Dotmatics Platform. Inventory enables the tracking of chemical samples, as well as biological entities and laboratory resources including instruments and consumables.

11 Feb 2015

Leukemia & Lymphoma Society announces launch of new partnership to empower people with lymphoma

The Leukemia & Lymphoma Society together with the Lymphoma Research Foundation, CancerCare, the Association of Community Cancer Centers and Genentech announced the launch of a new partnership, the Alliance for Resource Collaboration in Hematology (ARCH).

10 Feb 2015

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).

10 Feb 2015

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

AirStrip and The Batswadi Group have announced a strategic partnership to bring the AirStrip ONE mobile interoperability platform and the Sense4Baby wireless fetal/maternal monitoring system into ten African countries, with an initial launch in South Africa.

10 Feb 2015

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT")-based instruments and consumables to the worldwide life sciences industry, today announced the receipt of the first purchase order for its new Barozyme HT48 High-throughput System.

10 Feb 2015

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.

10 Feb 2015

Combination of coconut oil and exercise training can reduce blood pressure

Coconut oil is one of the few foods that can be classified as a "superfood." Its unique combination of fatty acids can have profound positive effects on health, including fat loss, better brain function and many other remarkable benefits.

10 Feb 2015

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.

10 Feb 2015

Researchers develop quality assurance tool for genome editing

A research team at Boston Children's Hospital's Program in Cellular and Molecular Medicine has developed a quality assurance tool for scientists using genome-editing technologies like the increasingly popular CRISPR. The assay, called high throughput genome translocation sequencing (HTGTS), rapidly gauges—for any given gene—these technologies' accuracy and their risk for causing potentially dangerous genomic collateral damage.

9 Feb 2015

Gilead Sciences, Mobiquity make significant healthcare investment in London

London's status as a leading centre for the life sciences, financial and digital industries has attracted significant new investment by two leading US companies, announced today as Mayor of London Boris Johnson visited Boston as part of a trade delegation to the East Coast of the USA.

9 Feb 2015

Biotechnology News and Research

MedNet Solutions bolsters its iMedNet Partner Program

BioMed Realty breaks ground on new 316,000 square foot campus in San Diego

Biotech experts to establish ethical guidelines in cellular biotechnology at BEINGS 2015

New study indicates that malaria-causing parasite is unlikely to cross from animals to humans

AMRI reports financial and operating results for Q4 and FY 2014

Epicore BioNetworks named one of 50 strongest companies on TSXV

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

ADDF, Pfizer's CTI collaborate to advance development of new drugs for Alzheimer's disease

Oncolytics' REOLYSIN receives FDA Orphan Drug Designation for treatment of ovarian cancer

Researchers close to novel therapy to treat levodopa-induced dyskinesia

Dotmatics releases new version of Inventory module

Leukemia & Lymphoma Society announces launch of new partnership to empower people with lymphoma

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

AirStrip, Batswadi announce strategic partnership to bring AirStrip products into Africa

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Synthetic Biologics reports positive results from SYN-004 Phase 1b trial to prevent C. difficile infection

Combination of coconut oil and exercise training can reduce blood pressure

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

Researchers develop quality assurance tool for genome editing

Gilead Sciences, Mobiquity make significant healthcare investment in London

Event guide: 3rd IMPACCT Real World Evidence Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News